Nomura Adjusts IRay Technology's Price Target to 149.73 Yuan From 175.49 Yuan, Keeps at Buy
Nomura Adjusts Shanghai United Imaging Healthcare's Price Target to 122.36 Yuan From 139.25 Yuan, Keeps at Neutral
Nomura Adjusts Yifeng Pharmacy Chain's Price Target to 41.09 Yuan From 49.56 Yuan, Keeps at Buy
Nomura Adjusts LBX Pharmacy Chain's Price Target to 34.87 Yuan From 35.52 Yuan, Keeps at Buy
UOB Kay Hian Upgrades Guangzhou Kingmed Diagnostics to Buy From Hold; Price Target Is 35 Yuan
Nomura Adjusts Joinn Laboratories' Price Target to 12.27 Yuan From 17.37 Yuan, Keeps at Neutral
Nomura Adjusts United Imaging Healthcare's Price Target to 139.25 Yuan From 132.88 Yuan, Keeps at Neutral
Nomura Adjusts IRay Technology's Price Target to 245.69 Yuan From 285.80 Yuan, Keeps at Buy
Nomura Adjusts Shanghai United Imaging Healthcare's Price Target to 132.88 Yuan From 134.26 Yuan, Keeps at Neutral
Nomura Adjusts MGI Tech Price Target to 15.35 Yuan From 22.14 Yuan, Keeps at Neutral
Nomura Adjusts Wuxi Apptec's Price Target to 62.75 Yuan From 99.16 Yuan, Keeps at Buy
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 51.12 Yuan From 49.24 Yuan, Keeps at Neutral
Nomura Adjusts LBX Pharmacy Chain's Price Target to 45.79 Yuan From 43.96 Yuan, Keeps at Buy
Nomura Adjusts Shanghai United Imaging Healthcare's Price Target to 134.26 Yuan From 117.54 Yuan, Keeps at Neutral
Nomura Downgrades Joinn Laboratories (China) to Neutral From Buy, Adjusts Price Target to HK$12.60 From HK$20.93
Analysts Are Bullish on These Healthcare Stocks: Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF), Mesoblast Limited (MEOBF)
Nomura Adjusts LBX Pharmacy Chain's Price Target to 43.96 Yuan From 44.28 Yuan, Keeps at Buy
Nomura Adjusts Joinn Laboratories (China)'s Price Target to HK$20.93 From HK$20.64, Keeps at Buy
Nomura Adjusts Shanghai United Imaging Healthcare's Price Target to 117.54 Yuan From 162.26 Yuan, Keeps at Neutral
Nomura Adjusts MGI Tech's Price Target to 77.79 Yuan From 87.28 Yuan, Keeps at Neutral